Mazdutide is an investigational peptide designed to activate both GLP-1 and glucagon receptors. It is currently being studied for its role in weight regulation, glycemic control, and metabolic health. As a dual agonist, it has drawn significant interest in the following research areas:
Weight Management
Mazdutide is being evaluated for its potential to reduce body weight by influencing appetite, energy expenditure, and fat metabolism.
Glycemic Control
Researchers are exploring its effects on blood glucose regulation through insulinotropic and glucagon-modulating pathways.
Metabolic Efficiency
Ongoing studies are examining its impact on energy balance, lipid metabolism, and mitochondrial activation.
 
How It Works
Mazdutide is a dual GLP-1 and glucagon receptor agonist. GLP-1 activation supports insulin secretion, delays gastric emptying, and promotes satiety. Concurrently, glucagon receptor activation may increase energy expenditure and promote lipolysis. By combining these two mechanisms, Mazdutide aims to address both sides of the metabolic equation: reducing caloric intake and enhancing caloric burn. This dual-action approach makes it a promising candidate for research targeting obesity and metabolic dysfunction.
 
⚠️ Important Notice:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use, and not for therapeutic or diagnostic applications.
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.